Cell and gene therapies offer transformative potential by targeting the cellular or genetic drivers of disease. Ancillary materials play a critical role in ensuring the safety and quality of the finished therapies, even though they are not intended to be part of the final product. Cayman provides two small‑molecule quality ranges: Ancillary Material and GMP Ancillary Material grades. These products meet the expectations outlined in USP <1043> Ancillary Materials for Cell, Gene, and Tissue‑Engineered Products and support consistent, reliable workflows as your programs advance from development to clinical and commercial stages.

View All Ancillary Materials